                         SEQUENCE LISTING

<110>  INVERSITE DE STRASBOURG ET AL
 
<120>  A CHIMERIC CONSTRUCT FOR DIAGNOSIS AND THERAPY OF 
       PAPILLOMAVIRUS-INDUCED CANCERS

<130>  B1743PC

<160>  17    

<170>  PatentIn version 3.5

<210>  1
<211>  129
<212>  PRT
<213>  artificial sequence

<220>
<223>  PDZ domain

<400>  1

Gly Ala Met Gly Lys Pro Phe Phe Thr Arg Asn Pro Ser Glu Leu Lys 
1               5                   10                  15      


Gly Lys Phe Ile His Thr Lys Leu Arg Lys Ser Ser Arg Gly Phe Gly 
            20                  25                  30          


Phe Thr Val Val Gly Gly Asp Glu Pro Asp Glu Phe Leu Gln Ile Lys 
        35                  40                  45              


Ser Leu Val Leu Asp Gly Pro Ala Ala Leu Asp Gly Lys Met Glu Thr 
    50                  55                  60                  


Gly Asp Val Ile Val Ser Val Asn Asp Thr Cys Val Leu Gly His Thr 
65                  70                  75                  80  


His Ala Gln Val Val Lys Ile Phe Gln Ser Ile Pro Ile Gly Ala Ser 
                85                  90                  95      


Val Asp Leu Glu Leu Cys Arg Gly Tyr Pro Leu Pro Phe Asp Pro Asp 
            100                 105                 110         


Asp Pro Asn Thr Ser Leu Val Thr Ser Val Ala Ile Leu Asp Lys Glu 
        115                 120                 125             


Pro 
    


<210>  2
<211>  12
<212>  PRT
<213>  artificial sequence

<220>
<223>  LxxLL consensus

<400>  2

Glu Leu Thr Leu Gln Glu Leu Leu Gly Glu Glu Arg 
1               5                   10          


<210>  3
<211>  144
<212>  PRT
<213>  artificial sequence

<220>
<223>  chimeric fusion polypeptide

<400>  3

Gly Ala Met Gly Lys Pro Phe Phe Thr Arg Asn Pro Ser Glu Leu Lys 
1               5                   10                  15      


Gly Lys Phe Ile His Thr Lys Leu Arg Lys Ser Ser Arg Gly Phe Gly 
            20                  25                  30          


Phe Thr Val Val Gly Gly Asp Glu Pro Asp Glu Phe Leu Gln Ile Lys 
        35                  40                  45              


Ser Leu Val Leu Asp Gly Pro Ala Ala Leu Asp Gly Lys Met Glu Thr 
    50                  55                  60                  


Gly Asp Val Ile Val Ser Val Asn Asp Thr Cys Val Leu Gly His Thr 
65                  70                  75                  80  


His Ala Gln Val Val Lys Ile Phe Gln Ser Ile Pro Ile Gly Ala Ser 
                85                  90                  95      


Val Asp Leu Glu Leu Cys Arg Gly Tyr Pro Leu Pro Phe Asp Pro Asp 
            100                 105                 110         


Asp Pro Asn Thr Ser Leu Val Thr Ser Val Ala Ile Leu Asp Lys Glu 
        115                 120                 125             


Pro Ala Ala Ala Glu Leu Thr Leu Gln Glu Leu Leu Gly Glu Glu Arg 
    130                 135                 140                 


<210>  4
<211>  144
<212>  PRT
<213>  artificial sequence

<220>
<223>  chimeric fusion polypeptide

<400>  4

Glu Leu Thr Leu Gln Glu Leu Leu Gly Glu Glu Arg Ala Ala Ala Gly 
1               5                   10                  15      


Ala Met Gly Lys Pro Phe Phe Thr Arg Asn Pro Ser Glu Leu Lys Gly 
            20                  25                  30          


Lys Phe Ile His Thr Lys Leu Arg Lys Ser Ser Arg Gly Phe Gly Phe 
        35                  40                  45              


Thr Val Val Gly Gly Asp Glu Pro Asp Glu Phe Leu Gln Ile Lys Ser 
    50                  55                  60                  


Leu Val Leu Asp Gly Pro Ala Ala Leu Asp Gly Lys Met Glu Thr Gly 
65                  70                  75                  80  


Asp Val Ile Val Ser Val Asn Asp Thr Cys Val Leu Gly His Thr His 
                85                  90                  95      


Ala Gln Val Val Lys Ile Phe Gln Ser Ile Pro Ile Gly Ala Ser Val 
            100                 105                 110         


Asp Leu Glu Leu Cys Arg Gly Tyr Pro Leu Pro Phe Asp Pro Asp Asp 
        115                 120                 125             


Pro Asn Thr Ser Leu Val Thr Ser Val Ala Ile Leu Asp Lys Glu Pro 
    130                 135                 140                 


<210>  5
<211>  8
<212>  PRT
<213>  artificial sequence

<220>
<223>  protein transduction domain

<400>  5

Arg Arg Arg Arg Arg Arg Arg Arg 
1               5               


<210>  6
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  protein transduction domain

<400>  6

Arg Arg Pro Arg Arg Pro Arg Arg Pro Arg Arg Pro Arg Arg Pro 
1               5                   10                  15  


<210>  7
<211>  16
<212>  PRT
<213>  artificial sequence

<220>
<223>  protein transduction domain

<400>  7

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  8
<211>  11
<212>  PRT
<213>  artificial sequence

<220>
<223>  protein transduction domain

<400>  8

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  9
<211>  435
<212>  DNA
<213>  artificial sequence

<220>
<223>  encoding chimeric fusion polypeptide

<400>  9
ggcgccatgg ggaaaccttt ttttacaaga aacccctctg agctgaaagg caagttcatt       60

cacacgaagc tacggaaaag cagccgaggc tttggcttca cggtggttgg aggagacgag      120

cctgatgagt tcctgcagat caagagcctc gtcctcgatg gtcctgccgc actggatggc      180

aagatggaga caggggatgt aattgtgagt gtgaatgaca cctgtgtttt gggacacaca      240

catgctcaag ttgtgaaaat cttccagtcc attcccattg gtgccagtgt ggaccttgaa      300

ctctgcagag gttatccatt gccttttgac ccggatgacc ctaatacaag tttagtgacc      360

tcggtggcca ttttggacaa agaaccagcg gccgccgagc tgaccctgca ggaattgctg      420

ggcgaggaac gttga                                                       435


<210>  10
<211>  53
<212>  DNA
<213>  artificial sequence

<220>
<223>  primer

<400>  10
acaagtttgt acaaaaaagc aggctatggg gaaacctttt tttacaagaa acc              53


<210>  11
<211>  91
<212>  DNA
<213>  artificial sequence

<220>
<223>  primer

<400>  11
accactttgt acaagaaagc tgggttcagc ccagatcctc ttctgagatg agtttttgtt       60

cgccgccgcc acgttcctcg cccagcaatt c                                      91


<210>  12
<211>  94
<212>  DNA
<213>  artificial sequence

<220>
<223>  primer

<400>  12
accactttgt acaagaaagc tgggttcagc ccagatcctc ttctgagatg agtttttgtt       60

cgccgccgcc tggttctttg tccaaaatgg ccac                                   94


<210>  13
<211>  48
<212>  DNA
<213>  artificial sequence

<220>
<223>  primer

<400>  13
acaagtttgt acaaaaaagc aggctaatgg cggccgccga ggctgacc                    48


<210>  14
<211>  471
<212>  DNA
<213>  artificial sequence

<220>
<223>  ORF chimera

<400>  14
atggggaaac ctttttttac aagaaacccc tctgagctga aaggcaagtt cattcacacg       60

aagctacgga aaagcagccg aggctttggc ttcacggtgg ttggaggaga cgagcctgat      120

gagttcctgc agatcaagag cctcgtcctc gatggtcctg ccgcactgga tggcaagatg      180

gagacagggg atgtaattgt gagtgtgaat gacacctgtg ttttgggaca cacacatgct      240

caagttgtga aaatcttcca gtccattccc attggtgcca gtgtggacct tgaactctgc      300

agaggttatc cattgccttt tgacccggat gaccctaata caagtttagt gacctcggtg      360

gccattttgg acaaagaacc agcggccgcc gagctgaccc tgcaggaatt gctgggcgag      420

gaacgtggcg gcggcgaaca aaaactcatc tcagaagagg atctgggctg a               471


<210>  15
<211>  426
<212>  DNA
<213>  artificial sequence

<220>
<223>  ORF PDZ

<400>  15
atggggaaac ctttttttac aagaaacccc tctgagctga aaggcaagtt cattcacacg       60

aagctacgga aaagcagccg aggctttggc ttcacggtgg ttggaggaga cgagcctgat      120

gagttcctgc agatcaagag cctcgtcctc gatggtcctg ccgcactgga tggcaagatg      180

gagacagggg atgtaattgt gagtgtgaat gacacctgtg ttttgggaca cacacatgct      240

caagttgtga aaatcttcca gtccattccc attggtgcca gtgtggacct tgaactctgc      300

agaggttatc cattgccttt tgacccggat gaccctaata caagtttagt gacctcggtg      360

gccattttgg acaaagaacc aggcggcggc gaacaaaaac tcatctcaga agaggatctg      420

ggctga                                                                 426


<210>  16
<211>  93
<212>  DNA
<213>  artificial sequence

<220>
<223>  ORF e6ap myc

<400>  16
atggcggccg ccgagctgac cctgcaggaa ttgctgggcg aggaacgtgg cggcggcgaa       60

caaaaactca tctcagaaga ggatctgggc tga                                    93


<210>  17
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  linker + LxxLL motif

<400>  17

Ala Ala Ala Glu Leu Thr Leu Gln Glu Leu Leu Gly Glu Glu Arg 
1               5                   10                  15  


